Protagen AG and Charles River Laboratories International have entered into a strategic marketing and sales alliance. The partnership with Protagen AG, an international specialist in the fields of in-vitro diagnostics and GMP-compliant protein analysis, allows Charles River Biopharmaceutical Services (BPS) to provide clients with services covering the entire range of protein analytics from detailed protein characterization to stability and lot release testing.
“The technology portfolio and the exceptional expertise of Charles River in the area of certified bioservices will synergistically complement the experience and competences of Protagen in the field of biotherapeutics and biosimilars. The customers in the pharmaceutical and biotech sector will profit from this alliance through the direct access to a comprehensive service portfolio,” said Dr. Stefan Müllner, chief executive officer of Protagen AG.
